Therefore, most of the patients with chronic phase (CP)-CML express a 210-kDa BCR-ABL1 (p210BCR-ABL1) coded by e13a2 or e14a2 BCR-ABL1 transcripts. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.